Cargando…
Stereotactic Body Radiotherapy as Treatment for Organ Confined Low- and Intermediate-Risk Prostate Carcinoma, a 7-Year Study
Objectives: Stereotactic body radiation therapy (SBRT) takes advantage of the prostate’s low α/β ratio to deliver a large radiation dose in few fractions. Initial studies on small groups of low-risk patients support SBRT’s potential for clinical efficacy while limiting treatment-related morbidity an...
Autores principales: | Katz, Alan Jay, Kang, Josephine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150980/ https://www.ncbi.nlm.nih.gov/pubmed/25229051 http://dx.doi.org/10.3389/fonc.2014.00240 |
Ejemplares similares
-
Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study
por: Katz, Alan Jay, et al.
Publicado: (2014) -
Stereotactic body radiotherapy for organ-confined prostate cancer
por: Katz, Alan J, et al.
Publicado: (2010) -
Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study
por: Katz, Alan, et al.
Publicado: (2014) -
Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure
por: Katz, Alan, et al.
Publicado: (2016) -
Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect?
por: Katz, Alan J., et al.
Publicado: (2011)